| Peer-Reviewed

Lateral Epicondylitis: A Novel Non-Invasive Treatment Approach

Received: 7 August 2014     Accepted: 1 September 2014     Published: 20 September 2014
Views:       Downloads:
Abstract

Objective: To evaluate the effectiveness of the TheraPoint Focal Pressure Support (TP-FPS) as a non-invasive treatment for pain associated with lateral Epicondylitis (LE). Design: Prospective cohort study. Participants: n = 25 study subjects (20 males and 5 females) ranging in age from 18-65 with pain in one upper limb either dominant (23) or non-dominant (2) associated with lateral epicondylitis for a minimum of six months. Interventions: Study participants were tasked to wear the TP-FPS for 3 hours per day for two weeks except when bathing or during main sleep hours. Outcome measures: Visual analog scale (VAS) pain score pre- and post-treatment period. Results: The combined (male and female) cohort average pre-treatment VAS pain score was 7.44 +/- 0.57. Post-treatment VAS pain score was 1.07 +/- 0.42, with a total reduction of 6.37 points and reached significance with p=0.0005. Male cohort demonstrated an average pre-treatment VAS pain score of 7.45 +/- 0.56. Post-treatment VAS pain score was 1.40 +/- 0.45, with a total reduction of 6.05 points and reached significance with p=0.006. Female cohort displayed an average pre-treatment VAS pain score of 7.40 +/- 1.92. Post-treatment VAS pain score was 1.70 +/- 1.14, with a total reduction of 5.70 and reached significance with p=0.001. No statistically significant difference was observed in the VAS pain score reduction between the male and female groups. Conclusion: The TP-FPS may indeed be a non-invasive therapeutic option for reducing pain associated with lateral epicondylitis.

Published in American Journal of Sports Science (Volume 2, Issue 5)
DOI 10.11648/j.ajss.20140205.11
Page(s) 111-114
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2014. Published by Science Publishing Group

Keywords

Lateral Epicondylitis, Elbow Pain, Non-Invasive, Pain Management, Pain Reduction

References
[1] Ajimsha, M. S., Chithra, S., & Thulasyammal, R. P. (2012). Effectiveness of myofascial release in the management of lateral epicondylitis in computer professionals. Arch Phys Med Rehabil, 93(4), 604-609. doi: 10.1016/j.apmr.2011.10.012
[2] Ashe, M. C., McCauley, T., & Khan, K. M. (2004). Tendinopathies in the upper extremity: a paradigm shift. J Hand Ther, 17(3), 329-334. doi: 10.1197/j.jht.2004.04.002
[3] Blanchette, M. A., & Normand, M. C. (2011). Augmented soft tissue mobilization vs natural history in the treatment of lateral epicondylitis: a pilot study. J Manipulative Physiol Ther, 34(2), 123-130. doi: 10.1016/j.jmpt.2010.12.001
[4] Chard, M. D., & Hazleman, B. L. (1989). Tennis elbow--a reappraisal. Br J Rheumatol, 28(3), 186-190.
[5] Chaudhury, S., de La Lama, M., Adler, R. S., Gulotta, L. V., Skonieczki, B., Chang, A., . . . Fealy, S. (2013). Platelet-rich plasma for the treatment of lateral epicondylitis: sonographic assessment of tendon morphology and vascularity (pilot study). Skeletal Radiol, 42(1), 91-97. doi: 10.1007/s00256-012-1518-y
[6] Chop, W. M., Jr. (1989). Tennis elbow. Postgrad Med, 86(5), 301-304, 307-308.
[7] Gabel, G. T. (1999). Acute and chronic tendinopathies at the elbow. Curr Opin Rheumatol, 11(2), 138-143.
[8] Hamilton, P. G. (1986). The prevalence of humeral epicondylitis: a survey in general practice. J R Coll Gen Pract, 36(291), 464-465.
[9] Jensen, M. P., Turner, J. A., Romano, J. M., & Fisher, L. D. (1999). Comparative reliability and validity of chronic pain intensity measures. Pain, 83(2), 157-162.
[10] Khan, K. M., Cook, J. L., Bonar, F., Harcourt, P., & Astrom, M. (1999). Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med, 27(6), 393-408.
[11] Kivi, P. (1983). The etiology and conservative treatment of humeral epicondylitis. Scand J Rehabil Med, 15(1), 37-41.
[12] Nirschl, R. P. (1992). Elbow tendinosis/tennis elbow. Clin Sports Med, 11(4), 851-870.
[13] Nourbakhsh, M. R., & Fearon, F. J. (2008). The effect of oscillating-energy manual therapy on lateral epicondylitis: a randomized, placebo-control, double-blinded study. J Hand Ther, 21(1), 4-13; quiz 14. doi: 10.1197/j.jht.2007.09.005
[14] Overend, T. J., Wuori-Fearn, J. L., Kramer, J. F., & MacDermid, J. C. (1999). Reliability of a patient-rated forearm evaluation questionnaire for patients with lateral epicondylitis. J Hand Ther, 12(1), 31-37.
[15] Rompe, J. D., Overend, T. J., & MacDermid, J. C. (2007). Validation of the Patient-rated Tennis Elbow Evaluation Questionnaire. J Hand Ther, 20(1), 3-10; quiz 11. doi: 10.1197/j.jht.2006.10.003
[16] Shiri, R., Viikari-Juntura, E., Varonen, H., & Heliovaara, M. (2006). Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol, 164(11), 1065-1074. doi: 10.1093/aje/kwj325
[17] Simons, D. G., Hong, C. Z., & Simons, L. S. (2002). Endplate potentials are common to midfiber myofacial trigger points. Am J Phys Med Rehabil, 81(3), 212-222.
[18] Walz, D. M., Newman, J. S., Konin, G. P., & Ross, G. (2010). Epicondylitis: pathogenesis, imaging, and treatment. Radiographics, 30(1), 167-184. doi: 10.1148/rg.301095078
[19] Hsieh, L.L., et al., Treatment of low back pain by acupressure and physical therapy: randomised controlled trial. BMJ, 2006. 332(7543): p. 696-700.
[20] Hsieh, L.L., et al., A randomized controlled clinical trial for low back pain treated by acupressure and physical therapy. Prev Med, 2004. 39(1): p. 168-76.
[21] Luo, D., X. Wang, and J. He, A comparison between acute pressure block of the sciatic nerve and acupressure: methodology, analgesia, and mechanism involved. J Pain Res, 2013. 6: p. 589-93.
Cite This Article
  • APA Style

    Christopher Bui. (2014). Lateral Epicondylitis: A Novel Non-Invasive Treatment Approach. American Journal of Sports Science, 2(5), 111-114. https://doi.org/10.11648/j.ajss.20140205.11

    Copy | Download

    ACS Style

    Christopher Bui. Lateral Epicondylitis: A Novel Non-Invasive Treatment Approach. Am. J. Sports Sci. 2014, 2(5), 111-114. doi: 10.11648/j.ajss.20140205.11

    Copy | Download

    AMA Style

    Christopher Bui. Lateral Epicondylitis: A Novel Non-Invasive Treatment Approach. Am J Sports Sci. 2014;2(5):111-114. doi: 10.11648/j.ajss.20140205.11

    Copy | Download

  • @article{10.11648/j.ajss.20140205.11,
      author = {Christopher Bui},
      title = {Lateral Epicondylitis: A Novel Non-Invasive Treatment Approach},
      journal = {American Journal of Sports Science},
      volume = {2},
      number = {5},
      pages = {111-114},
      doi = {10.11648/j.ajss.20140205.11},
      url = {https://doi.org/10.11648/j.ajss.20140205.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajss.20140205.11},
      abstract = {Objective: To evaluate the effectiveness of the TheraPoint Focal Pressure Support (TP-FPS) as a non-invasive treatment for pain associated with lateral Epicondylitis (LE). Design: Prospective cohort study. Participants: n = 25 study subjects (20 males and 5 females) ranging in age from 18-65 with pain in one upper limb either dominant (23) or non-dominant (2) associated with lateral epicondylitis for a minimum of six months. Interventions: Study participants were tasked to wear the TP-FPS for 3 hours per day for two weeks except when bathing or during main sleep hours. Outcome measures: Visual analog scale (VAS) pain score pre- and post-treatment period. Results: The combined (male and female) cohort average pre-treatment VAS pain score was 7.44 +/- 0.57. Post-treatment VAS pain score was 1.07 +/- 0.42, with a total reduction of 6.37 points and reached significance with p=0.0005. Male cohort demonstrated an average pre-treatment VAS pain score of 7.45 +/- 0.56. Post-treatment VAS pain score was 1.40 +/- 0.45, with a total reduction of 6.05 points and reached significance with p=0.006. Female cohort displayed an average pre-treatment VAS pain score of 7.40 +/- 1.92. Post-treatment VAS pain score was 1.70 +/- 1.14, with a total reduction of 5.70 and reached significance with p=0.001. No statistically significant difference was observed in the VAS pain score reduction between the male and female groups. Conclusion: The TP-FPS may indeed be a non-invasive therapeutic option for reducing pain associated with lateral epicondylitis.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Lateral Epicondylitis: A Novel Non-Invasive Treatment Approach
    AU  - Christopher Bui
    Y1  - 2014/09/20
    PY  - 2014
    N1  - https://doi.org/10.11648/j.ajss.20140205.11
    DO  - 10.11648/j.ajss.20140205.11
    T2  - American Journal of Sports Science
    JF  - American Journal of Sports Science
    JO  - American Journal of Sports Science
    SP  - 111
    EP  - 114
    PB  - Science Publishing Group
    SN  - 2330-8540
    UR  - https://doi.org/10.11648/j.ajss.20140205.11
    AB  - Objective: To evaluate the effectiveness of the TheraPoint Focal Pressure Support (TP-FPS) as a non-invasive treatment for pain associated with lateral Epicondylitis (LE). Design: Prospective cohort study. Participants: n = 25 study subjects (20 males and 5 females) ranging in age from 18-65 with pain in one upper limb either dominant (23) or non-dominant (2) associated with lateral epicondylitis for a minimum of six months. Interventions: Study participants were tasked to wear the TP-FPS for 3 hours per day for two weeks except when bathing or during main sleep hours. Outcome measures: Visual analog scale (VAS) pain score pre- and post-treatment period. Results: The combined (male and female) cohort average pre-treatment VAS pain score was 7.44 +/- 0.57. Post-treatment VAS pain score was 1.07 +/- 0.42, with a total reduction of 6.37 points and reached significance with p=0.0005. Male cohort demonstrated an average pre-treatment VAS pain score of 7.45 +/- 0.56. Post-treatment VAS pain score was 1.40 +/- 0.45, with a total reduction of 6.05 points and reached significance with p=0.006. Female cohort displayed an average pre-treatment VAS pain score of 7.40 +/- 1.92. Post-treatment VAS pain score was 1.70 +/- 1.14, with a total reduction of 5.70 and reached significance with p=0.001. No statistically significant difference was observed in the VAS pain score reduction between the male and female groups. Conclusion: The TP-FPS may indeed be a non-invasive therapeutic option for reducing pain associated with lateral epicondylitis.
    VL  - 2
    IS  - 5
    ER  - 

    Copy | Download

Author Information
  • Department of Physical Medicine and Rehabilitation, West Los Angeles Veterans Administration/UCLA, Los Angeles, CA, USA

  • Sections